Recruiting
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
NCT05977907
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Providence Cancer Institute Portland, Oregon, United States